NASDAQ · MYCM

SSGA Active Trust State Street My2033 Corporate Bond ETF (MYCM)

$23.47−0.54%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$23.47▼ 6.35% in range
Sep 29, 2025Low $23.47 · High $25.27Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

SSGA Active Trust State Street My2033 Corporate Bond ETF closed at $23.47 on Sep 28, down 0.54%, within 0.0% of its 52-week closing low. Volume of 589 shares was 0.89× its 20-day average (close to normal).

Split-adjusted performance: -3.5% over one month, -4.1% over six months, -6.1% over one year.

Short interest was 244 shares at the Sep 15 settlement, up 114.0% from the prior report (1.0 days to cover).

Market cap$8.2M350.0K shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield4.64%$0.0908 last paid
52-week range23.47 – 25.27−7.1% from high
Volume5890.89× 20-day avg
Volatility · 60d4.6%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −1.8%1M −3.5%3M −5.2%6M −4.1%YTD −6.0%1Y −6.1%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short244+114.0% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d49.6%of daily volume

News about SSGA Active Trust State Street My2033 Corporate Bond ETF

All news →

No recent articles focused on SSGA Active Trust State Street My2033 Corporate Bond ETF.

Quick answers

What is MYCM's market cap?
$8.21M, based on the Sep 28 close of $23.47.
Does SSGA Active Trust State Street My2033 Corporate Bond ETF pay a dividend?
Yes. The latest regular dividend was $0.0908 per share (ex-date Sep 1), an annualised yield of 4.64%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology